Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors

Clinical trial NCT03065062 · SUSPENDED

Trial details

NCT number: NCT03065062
Sponsor: Dana-Farber Cancer Institute
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer Squamous Cell Solid Tumors Head & Neck Cancer Pancreatic Cancer

Start date: 2017-02-28
Primary completion: 2026-12-31
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.